Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients | BMC Cancer | Full Text

Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients | BMC Cancer | Full Text

Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients

Immunosenescence biomarkers and peripheral blood parameters are evaluated separately as possible predictive markers of immunotherapy. Here, we illustrate the use of a causal inference model to identify predict...

Authors:Patricia Lorenzo-Luaces, Lizet Sanchez, Danay Saavedra, Tania Crombet, Wim Van der Elst, Ariel Alonso, Geert Molenberghs and Agustin Lage

Citation:BMC Cancer 2020 20:772

Content type:Research article

 

Published on: 17 August 2020

• ViewFull Text
 
• ViewPDF